GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Lianhuan Pharmaceutical Co Ltd (SHSE:600513) » Definitions » Shiller PE Ratio

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Shiller PE Ratio : 29.15 (As of May. 13, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Jiangsu Lianhuan Pharmaceutical Co Shiller PE Ratio?

As of today (2024-05-13), Jiangsu Lianhuan Pharmaceutical Co's current share price is ¥9.62. Jiangsu Lianhuan Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 was ¥0.33. Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio for today is 29.15.

The historical rank and industry rank for Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SHSE:600513' s Shiller PE Ratio Range Over the Past 10 Years
Min: 24.28   Med: 51.32   Max: 243.3
Current: 29.15

During the past years, Jiangsu Lianhuan Pharmaceutical Co's highest Shiller PE Ratio was 243.30. The lowest was 24.28. And the median was 51.32.

SHSE:600513's Shiller PE Ratio is ranked worse than
57.36% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs SHSE:600513: 29.15

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jiangsu Lianhuan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.33 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Jiangsu Lianhuan Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Lianhuan Pharmaceutical Co Shiller PE Ratio Chart

Jiangsu Lianhuan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.10 45.66 37.53 31.98 34.59

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.01 31.69 31.24 34.59 27.55

Competitive Comparison of Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio falls into.



Jiangsu Lianhuan Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=9.62/0.33
=29.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jiangsu Lianhuan Pharmaceutical Co's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Jiangsu Lianhuan Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.11/114.6694*114.6694
=0.110

Current CPI (Mar. 2024) = 114.6694.

Jiangsu Lianhuan Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.046 98.200 0.054
201409 0.047 98.900 0.054
201412 0.036 99.000 0.042
201503 0.041 99.900 0.047
201506 0.041 99.500 0.047
201509 0.062 100.500 0.071
201512 0.043 100.600 0.049
201603 0.046 102.200 0.052
201606 0.054 101.400 0.061
201609 0.060 102.400 0.067
201612 0.059 102.600 0.066
201703 0.050 103.200 0.056
201706 0.070 103.100 0.078
201709 0.050 104.100 0.055
201712 0.070 104.500 0.077
201803 0.060 105.300 0.065
201806 0.080 104.900 0.087
201809 0.060 106.600 0.065
201812 0.059 106.500 0.064
201903 0.060 107.700 0.064
201906 0.080 107.700 0.085
201909 0.070 109.800 0.073
201912 0.060 111.200 0.062
202003 0.070 112.300 0.071
202006 0.090 110.400 0.093
202009 0.120 111.700 0.123
202012 0.080 111.500 0.082
202103 0.090 112.662 0.092
202106 0.100 111.769 0.103
202109 0.110 112.215 0.112
202112 0.110 113.108 0.112
202203 0.110 114.335 0.110
202206 0.120 114.558 0.120
202209 0.117 115.339 0.116
202212 0.140 115.116 0.139
202303 0.110 115.116 0.110
202306 0.100 114.558 0.100
202309 0.095 115.339 0.094
202312 0.160 114.669 0.160
202403 0.110 114.669 0.110

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Jiangsu Lianhuan Pharmaceutical Co  (SHSE:600513) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Jiangsu Lianhuan Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Jiangsu Lianhuan Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Business Description

Traded in Other Exchanges
N/A
Address
No. 21 Wenfeng Road, Jiangsu Province, Yangzhou, Jiangsu, CHN, 225009
Jiangsu Lianhuan Pharmaceutical Co Ltd is engaged in producing benign prostatic hyperplasia, allergy and cardiovascular drugs.

Jiangsu Lianhuan Pharmaceutical Co (SHSE:600513) Headlines

No Headlines